---
title: "Precision Drilling Q2 2026 earnings preview"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293978931.md"
description: "Precision Drilling (PDS) is set to report Q2 2026 earnings on July 28 after market close. Consensus estimates project EPS of $0.28 and revenue of $311.71M, down 23.4% year-over-year. Recent analyst sentiment shows mixed revisions: EPS has seen four downward and one upward adjustment over the last three months, while revenue estimates have experienced five upward revisions with no downward changes."
datetime: "2026-07-27T21:54:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293978931.md)
  - [en](https://longbridge.com/en/news/293978931.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293978931.md)
generator: "portal-rs"
---

# Precision Drilling Q2 2026 earnings preview

Precision Drilling (PDS) is scheduled to announce Q2 earnings results on Tuesday, July 28th, after market close. The consensus EPS Estimate is $0.28 and the consensus Revenue Estimate is $311.71M (-23.4% Y/Y). Over the last 3 months, EPS estimates have seen 1 upward revision and 4 downward. Revenue estimates have seen 5 upward revisions and 0 downw...

### Related Stocks

- [PDS.US](https://longbridge.com/en/quote/PDS.US.md)

## Related News & Research

- [Precision Drilling (NYSE:PDS) Share Price Crosses Above 200-Day Moving Average   - Time to Sell?](https://longbridge.com/en/news/281314637.md)
- [Precision Drilling (PDS) Projected to Post Earnings on Wednesday](https://longbridge.com/en/news/283601285.md)
- [Kenmare Resources GAAP EPS of -$0.38, revenue of $149.1M; on track to achieve 2026 shipments guidance](https://longbridge.com/en/news/296317070.md)
- [HCW Biologics Inc. Q2 2026: Revenue $135.6K, EPS $(11.58) — 10-Q Summary](https://longbridge.com/en/news/295968025.md)
- [HCW Biologics says Q1 2026 financials cannot be relied on due to EPS misstatement](https://longbridge.com/en/news/295965944.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**